K&L Gates

K&L Gates, Singapore’s Straits Law Practice January 1 Combination Strengthens Firm’s Global, Local Offerings Read release.
Brexit Audit Tool Assists Clients in Assessing Exposure to UK Departure from EU. Read release.
Legal Decision-Makers Again Identify K&L Gates Among 20 Strongest Global Law Firm Brands. Read release.
Firm Advises Signal Energy on 333MW Darlington Solar Farm. Read release.
Four-Lawyer Chicago Team Bolsters Data Privacy, Cybersecurity, and Intellectual Property Practices. Read release.
Research Triangle Park Office Welcomes Health Care Partner. Read release.
Firm Adds Top Construction Partner to Sydney Office. Read release.
Firm Joins Belgium Legal Diversity & Inclusion Alliance. Read release.
K&L Gates Advises on €372 Million Ukrainian Wind Power Project. Read release.

A Guide to Political and Lobbying Activities. The latest edition of A Guide to Political and Lobbying Activities is required reading for anyone engaged in, or overseeing, government relations and political activities, including lobbying, campaign contributions, and PACs. Get it here.
Opportunity Zones. The U.S. Department of Treasury released proposed regulations on Opportunity Zones. Learn more about Opportunity Zones and how our OZ team can help you understand and implement the program and maximize its benefits.
Podcast: Health Care Triage. Our lawyers cover the latest health law developments in our ongoing podcast, Triage: Rapid Legal Lessons for Busy Health Care Professionals. Click here to listen.

K&L Gates Advises II-VI Incorporated on US$3.2 Billion Acquisition Agreement with Finisar Corporation. K&L Gates represented II-VI Incorporated in its entry into a definitive merger agreement with Finisar Corporation.
M&A Atlas Award for Cross-Border Deal of the Year. K&L Gates will receive a 2018 Americas M&A Atlas Award for its work representing Patricia Industries on the acquisition of healthcare product specialty distributor Sarnova Holdings, Inc.
K&L Gates Advises Axonics on $138 Million IPO. K&L Gates recently advised Axonics Modulation Technologies, Inc. on its successful initial public offering of 9.2 million shares of common stock.


	A \| B \| C \| D \| E \| F \| G \| H \| I \| J \| K \| L \| M \| N \| O \| P \| Q \| R \| S \| T \| U \| V \| W \| X \| Y \| Z Advanced Search